로딩 중…
지수 로딩 중…
NEXTBIOMEDICAL Co., Ltd.
389650· KOSDAQ· Health Care· Health Care Equipment & Services
₩40,300+0.37%
2026-06-19
Price Chart
NEXTBIOMEDICAL Co., Ltd.-11.72%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 333.57B KRW |
| Revenue | 16.82B KRW |
| Net Income | -49.8M KRW |
| Total Assets | 59.85B KRW |
| Net Assets | 48.94B KRW |
| Employees | 72 |
| Value | |
| P/B | 6.82x |
| P/S | 19.83x |
| FCF Yield | -0.57% |
| Profitability | |
| ROE | -0.10% |
| ROA | -0.08% |
| Op. Margin | -5.74% |
| Revenue Growth | 9.22% |
| Earnings Growth | -101.19% |
| Financial Health | |
| Debt Ratio | 122.31% |
| Total Debt | 0 KRW |
| FCF | -1.90B KRW |
| Cash | 4.02B KRW |
| Current Ratio | 5.11x |
| Performance | |
| 1Y Return | -11.72% |
| 1M Return | -14.26% |
| From 52W High | -60.10% |
| 1Y MDD | -60.31% |
| Trading | |
| Volume | 58,537 shares |
| Foreign Own. | 0.64% |
| Per Share | |
| EPS | -4 KRW |
| BPS | 5,965 KRW |
Company Info
Established in 2014, NEXT BIOMEDICAL is an innovative bio-solution company specially listed on the KOSDAQ market as a technology growth company in 2024. Leveraging polymer and drug delivery system technologies, the company develops products like hemostatic agents for endoscopy and vascular embolization microspheres, earning recognition for its technological prowess and innovation through FDA and CE certifications. It is pursuing the establishment of global distribution networks and sales channels by signing distribution rights agreements in the US, Europe, and Japan through partnerships with global medical device companies. NEXT BIOMEDICAL was established in 2014 and is headquartered in Yeonsu-gu, Incheon.